News
FDA Clears Combination Therapy for BRCA2 Prostate Cancer
Pune, India | December 15, 2025 The U.S. FDA has approved niraparib combined with abiraterone acetate and prednisone for adults with BRCA2 prostate cancer, specifically
Read More